ABS Global to Acquire 51% of In Vitro Brazil World’s Leading Commercial Provider of Bovine In-Vitro Fertilization Technology
PUNE, India (February 16, 2015)— ABS® Global, Inc., the world leader in bovine genetics, reproduction services,
and artificial insemination technologies, today announces that it has signed an agreement for the acquisition of
51% of In Vitro Brasil S.A. (IVB®). IVB is a leading biotechnology company focused on the production of bovine
embryos through in-vitro fertilization (IVF). IVB is based in Brazil and operates in 13 countries, including the United
States, Colombia, and Uruguay.
This transaction strengthens ABS’s global leadership in the development and delivery of differentiated bovine
genetics through the introduction of IVF technology. With ABS’s support and established global presence, IVB will
be well-positioned to meet the growing demand for IVF in the dairy industry—enabling farmers to accelerate
genetic improvement in their herds.